Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Alpha Thalassemia Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 Folic Acid 1.4.3 Deferasirox 1.4.4 Deferiprone 1.4.5 Hydroxyurea 1.5 Market by Application 1.5.1 Global Alpha Thalassemia Treatment Market Share by Application (2019-2025) 1.5.2 Hospitals 1.5.3 Ambulatory Surgical Centers 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Alpha Thalassemia Treatment Market Size 2.2 Alpha Thalassemia Treatment Growth Trends by Regions 2.2.1 Alpha Thalassemia Treatment Market Size by Regions (2019-2025) 2.2.2 Alpha Thalassemia Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Alpha Thalassemia Treatment Market Size by by Players 3.1.1 Global Alpha Thalassemia Treatment Revenue by by Players (2014-2019) 3.1.2 Global Alpha Thalassemia Treatment Revenue Market Share by by Players (2014-2019) 3.1.3 Global Alpha Thalassemia Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Alpha Thalassemia Treatment Key Players Head office and Area Served 3.3 Key Players Alpha Thalassemia Treatment Product/Solution/Service 3.4 Date of Enter into Alpha Thalassemia Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Alpha Thalassemia Treatment Market Size by Type (2014-2019) 4.2 Global Alpha Thalassemia Treatment Market Size by Application (2014-2019) 5 North America 5.1 North America Alpha Thalassemia Treatment Market Size (2014-2019) 5.2 Alpha Thalassemia Treatment Key Players in North America 5.3 North America Alpha Thalassemia Treatment Market Size by Type 5.4 North America Alpha Thalassemia Treatment Market Size by Application 6 Europe 6.1 Europe Alpha Thalassemia Treatment Market Size (2014-2019) 6.2 Alpha Thalassemia Treatment Key Players in Europe 6.3 Europe Alpha Thalassemia Treatment Market Size by Type 6.4 Europe Alpha Thalassemia Treatment Market Size by Application 7 China 7.1 China Alpha Thalassemia Treatment Market Size (2014-2019) 7.2 Alpha Thalassemia Treatment Key Players in China 7.3 China Alpha Thalassemia Treatment Market Size by Type 7.4 China Alpha Thalassemia Treatment Market Size by Application 8 Japan 8.1 Japan Alpha Thalassemia Treatment Market Size (2014-2019) 8.2 Alpha Thalassemia Treatment Key Players in Japan 8.3 Japan Alpha Thalassemia Treatment Market Size by Type 8.4 Japan Alpha Thalassemia Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Alpha Thalassemia Treatment Market Size (2014-2019) 9.2 Alpha Thalassemia Treatment Key Players in Southeast Asia 9.3 Southeast Asia Alpha Thalassemia Treatment Market Size by Type 9.4 Southeast Asia Alpha Thalassemia Treatment Market Size by Application 10 India 10.1 India Alpha Thalassemia Treatment Market Size (2014-2019) 10.2 Alpha Thalassemia Treatment Key Players in India 10.3 India Alpha Thalassemia Treatment Market Size by Type 10.4 India Alpha Thalassemia Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Alpha Thalassemia Treatment Market Size (2014-2019) 11.2 Alpha Thalassemia Treatment Key Players in Central & South America 11.3 Central & South America Alpha Thalassemia Treatment Market Size by Type 11.4 Central & South America Alpha Thalassemia Treatment Market Size by Application 12 International Players Profiles 12.1 GlaxoSmithKline 12.1.1 GlaxoSmithKline Company Details 12.1.2 Company Description and Business Overview 12.1.3 Alpha Thalassemia Treatment Introduction 12.1.4 GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business (2014-2019)) 12.1.5 GlaxoSmithKline Recent Development 12.2 Novartis AG 12.2.1 Novartis AG Company Details 12.2.2 Company Description and Business Overview 12.2.3 Alpha Thalassemia Treatment Introduction 12.2.4 Novartis AG Revenue in Alpha Thalassemia Treatment Business (2014-2019) 12.2.5 Novartis AG Recent Development 12.3 Bellicum Pharmaceuticals 12.3.1 Bellicum Pharmaceuticals Company Details 12.3.2 Company Description and Business Overview 12.3.3 Alpha Thalassemia Treatment Introduction 12.3.4 Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business (2014-2019) 12.3.5 Bellicum Pharmaceuticals Recent Development 12.4 Acceleron Pharma 12.4.1 Acceleron Pharma Company Details 12.4.2 Company Description and Business Overview 12.4.3 Alpha Thalassemia Treatment Introduction 12.4.4 Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business (2014-2019) 12.4.5 Acceleron Pharma Recent Development 12.5 Johnson & Johnson 12.5.1 Johnson & Johnson Company Details 12.5.2 Company Description and Business Overview 12.5.3 Alpha Thalassemia Treatment Introduction 12.5.4 Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business (2014-2019) 12.5.5 Johnson & Johnson Recent Development 12.6 Merck & Co. 12.6.1 Merck & Co. Company Details 12.6.2 Company Description and Business Overview 12.6.3 Alpha Thalassemia Treatment Introduction 12.6.4 Merck & Co. Revenue in Alpha Thalassemia Treatment Business (2014-2019) 12.6.5 Merck & Co. Recent Development 12.7 Gilead Sciences, Inc. 12.7.1 Gilead Sciences, Inc. Company Details 12.7.2 Company Description and Business Overview 12.7.3 Alpha Thalassemia Treatment Introduction 12.7.4 Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business (2014-2019) 12.7.5 Gilead Sciences, Inc. Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Alpha Thalassemia Treatment Key Market Segments Table Key Players Alpha Thalassemia Treatment Covered Table Global Alpha Thalassemia Treatment Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Folic Acid Figures Table Key Players of Folic Acid Figuer Deferasirox Figures Table Key Players of Deferasirox Figuer Deferiprone Figures Table Key Players of Deferiprone Figuer Hydroxyurea Figures Table Key Players of Hydroxyurea Table Global Alpha Thalassemia Treatment Market Size Growth by Application 2019-2025 (Million US$) Figure Global Alpha Thalassemia Treatment Market Share by Application in 2018 & 2025 Figure Hospitals Case Studies Figure Ambulatory Surgical Centers Case Studies Figure Others Case Studies Figure Alpha Thalassemia Treatment Report Years Considered Figure Global Alpha Thalassemia Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global Alpha Thalassemia Treatment Market Size by Regions 2019-2025 (Million US$) Table Global Alpha Thalassemia Treatment Market Size by Regions 2019-2025 (Million US$) Table Global Alpha Thalassemia Treatment Market Share by Regions 2014-2019 Figure Global Alpha Thalassemia Treatment Market Share by Regions 2014-2019 Figure Global Alpha Thalassemia Treatment Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Alpha Thalassemia Treatment Revenue by by Players (2014-2019) (Million US$) Table Global Alpha Thalassemia Treatment Market Share by by Players (2014-2019) Figure Global Alpha Thalassemia Treatment Market Share by by Players in 2018 Table Global Alpha Thalassemia Treatment by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Alpha Thalassemia Treatment Product/Solution/Service Table Date of Enter into Alpha Thalassemia Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Alpha Thalassemia Treatment Market Size by Type (2014-2019) (Million US$) Table Global Alpha Thalassemia Treatment Market Size Share by Type (2014-2019) Figure Global Alpha Thalassemia Treatment Market Size Market Share by Type (2014-2019) Table Global Alpha Thalassemia Treatment Market Size by Application (2014-2019) (Million US$) Table Global Alpha Thalassemia Treatment Market Size Share by Application (2014-2019) Figure Global Alpha Thalassemia Treatment Market Size Market Share by Application (2014-2019) Figure Global Alpha Thalassemia Treatment Revenue Market Share by Application in 2018 Figure North America Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$) Table North America Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$) Table North America Key Players Alpha Thalassemia Treatment Market Share (2018-2019) Table North America Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$) Table North America Alpha Thalassemia Treatment Market Share by Type 2014-2019 Table North America Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$) Table North America Alpha Thalassemia Treatment Market Share by Application 2014-2019 Figure Europe Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players Alpha Thalassemia Treatment Market Share (2018-2019) Table Europe Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$) Table Europe Alpha Thalassemia Treatment Market Share by Type 2014-2019 Table Europe Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$) Table Europe Alpha Thalassemia Treatment Market Share by Application 2014-2019 Figure China Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$) Table China Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$) Table China Key Players Alpha Thalassemia Treatment Market Share (2018-2019) Table China Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$) Table China Alpha Thalassemia Treatment Market Share by Type 2014-2019 Table China Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$) Table China Alpha Thalassemia Treatment Market Share by Application 2014-2019 Figure Japan Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players Alpha Thalassemia Treatment Market Share (2018-2019) Table Japan Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$) Table Japan Alpha Thalassemia Treatment Market Share by Type 2014-2019 Table Japan Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$) Table Japan Alpha Thalassemia Treatment Market Share by Application 2014-2019 Figure Southeast Asia Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Alpha Thalassemia Treatment Market Share (2018-2019) Table Southeast Asia Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Alpha Thalassemia Treatment Market Share by Type 2014-2019 Table Southeast Asia Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Alpha Thalassemia Treatment Market Share by Application 2014-2019 Figure India Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$) Table India Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$) Table India Key Players Alpha Thalassemia Treatment Market Share (2018-2019) Table India Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$) Table India Alpha Thalassemia Treatment Market Share by Type 2014-2019 Table India Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$) Table India Alpha Thalassemia Treatment Market Share by Application 2014-2019 Figure Central & South America Alpha Thalassemia Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players Alpha Thalassemia Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players Alpha Thalassemia Treatment Market Share (2018-2019) Table Central & South America Alpha Thalassemia Treatment Market Size by Type 2014-2019 (Million US$) Table Central & South America Alpha Thalassemia Treatment Market Share by Type 2014-2019 Table Central & South America Alpha Thalassemia Treatment Market Size by Application 2014-2019 (Million US$) Table Central & South America Alpha Thalassemia Treatment Market Share by Application 2014-2019 Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019) Table GlaxoSmithKline Recent Development Table Novartis AG Company Details Table Novartis AG Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$) Figure Novartis AG Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019) Table Novartis AG Recent Development Table Bellicum Pharmaceuticals Company Details Table Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$) Figure Bellicum Pharmaceuticals Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019) Table Bellicum Pharmaceuticals Recent Development Table Acceleron Pharma Company Details Table Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$) Figure Acceleron Pharma Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019) Table Acceleron Pharma Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$) Figure Johnson & Johnson Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019) Table Johnson & Johnson Recent Development Table Merck & Co. Company Details Table Merck & Co. Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$) Figure Merck & Co. Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019) Table Merck & Co. Recent Development Table Gilead Sciences, Inc. Company Details Table Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business 2014-2019 (Million US$) Figure Gilead Sciences, Inc. Revenue Growth Rate in Alpha Thalassemia Treatment Business (2014-2019) Table Gilead Sciences, Inc. Recent Development Table Global Alpha Thalassemia Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global Alpha Thalassemia Treatment Market Size Share by Regions (2019-2025) Figure Global Alpha Thalassemia Treatment Market Size Share by Regions in 2025 Figure North America Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD) Figure China Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD) Figure India Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Alpha Thalassemia Treatment Market Size Forecast (2019-2025)(Million USD) Table Global Alpha Thalassemia Treatment Market Size by Product (2019-2025) (Million US$) Figure Global Alpha Thalassemia Treatment Market Size by Product (2019-2025) Figure Global Alpha Thalassemia Treatment Market Size by Product in 2025 Table Global Alpha Thalassemia Treatment Market Size by Application (2019-2025) (Million US$) Figure Global Alpha Thalassemia Treatment Market Size by Application (2019-2025) Figure Global Alpha Thalassemia Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GlaxoSmithKline Novartis AG Bellicum Pharmaceuticals Acceleron Pharma Johnson & Johnson Merck & Co. Gilead Sciences, Inc.